Cargando…
基于分子标志的非小细胞肺癌术后复发预测专家共识
Significant progress has been made in lung cancer screening, surgery, chemoradiation, targeted therapy, and immunotherapy recently. Surgical resection is the most important treatment for localized non-small cell lung cancer (NSCLC) so far, but there are still many patients who develop local recurren...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619343/ https://www.ncbi.nlm.nih.gov/pubmed/36285390 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.102.44 |
Ejemplares similares
-
非小细胞肺癌术后辅助治疗中国胸外科专家共识(2018版)
Publicado: (2018) -
中国埃克替尼治疗非小细胞肺癌专家共识(2015版)
Publicado: (2015) -
中国埃克替尼治疗非小细胞肺癌专家共识(2016年版)
Publicado: (2016) -
晚期非小细胞肺癌抗血管生成药物治疗中国专家共识(2019版)
Publicado: (2019) -
非小细胞肺癌PD-L1免疫组织化学检测规范中国专家共识
Publicado: (2020)